SCHEMBL6063348

SCHEMBL6063348

O=[C]N[C@@H](CCc1ccccc1)[C@H](O)c1nc2ccccc2o1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.40
CES1 P23141 1/20 0.40
DAGLA Q9Y4D2 1/20 0.40
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37
MAPT P10636 2/20 0.37
LMNA P02545 1/20 0.37
PTPN1 P18031 3/20 0.36
XDH P47989 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6462287 0.82 FAAH (0.44) FAAHCES1DAGLAHDAC3HDAC4
SCHEMBL7561710 0.78 FAAH (0.42) FAAHCES1DAGLAMAPTLMNA
SCHEMBL5431040 0.78 FAAH (0.42) FAAHCES1DAGLAMAPTLMNA
SCHEMBL6462278 0.78 FAAH (0.42) FAAHCES1DAGLAMAPTLMNA
SCHEMBL7732346 0.78 FAAH (0.42) FAAHCES1DAGLAMAPTLMNA
SCHEMBL5731227 0.78 CTSK (0.46) MAPTLMNAXDHRAB9ASMN1; SMN2
SCHEMBL5731226 0.78 CTSK (0.46) MAPTLMNAXDHRAB9ASMN1; SMN2
SCHEMBL6462563 0.76 KDM4E (0.43) MAPTLMNAPTPN1CYP1A2CYP3A4
SCHEMBL6466197 0.75 FAAH (0.36) FAAHCES1DAGLALMNAPTPN1
SCHEMBL7466136 0.75 FAAH (0.36) FAAHCES1DAGLALMNAPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1694357-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2006-08-30 EP disclosed
WO-2005058348-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2005-06-30 WO disclosed